Urine kidney injury biomarkers and risks of cardiovascular disease events and All-Cause death: The CRIC study

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 5, 2017, Pages 761-771

  Park, Meyeon ^a   Hsu, Chi Yuan ^a   Go, Alan S ^b   Feldman, Harold I ^c   Xie, Dawei ^c   Zhang, Xiaoming ^c   Mifflin, Theodore ^c   Waikar, Sushrut S ^d   Sabbisetti, Venkata S ^d   Bonventre, Joseph V ^d   Coresh, Josef ^e   Nelson, Robert G ^f   Kimmel, Paul L ^f   Kusek, John W ^f   Rahman, Mahboob ^g   Schelling, Jeffrey R ^g   Vasan, Ramachandran S ^h   Liu, Kathleen D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e JOHNS HOPKINS UNIVERSITY   (United States)

^f NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^g CASE WESTERN RESERVE UNIVERSITY   (United States)

^h BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylglucosaminidase; Aged; Atherosclerosis; Biomarkers; Cardiovascular disease; Chronic kidney disease; Creatinine; FABP1 protein, human; Fatty Acid Binding Proteins; Female; Follow Up Studies; Heart failure; Humans; Lipocalin 2; Middle Aged; Mortality risk; Myocardial Infarction; Peripheral Arterial Disease; Renal Insufficiency, Chronic; Risk factors; Self Report; Stroke

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; CREATININE; FATTY ACID BINDING PROTEIN; KIDNEY INJURY MOLECULE 1; N ACETYL BETA GLUCOSAMINIDASE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; ACETYLGLUCOSAMINIDASE; FABP1 PROTEIN, HUMAN; HAVCR1 PROTEIN, HUMAN; LCN2 PROTEIN, HUMAN;

ADULT; ARTICLE; CARDIOVASCULAR RISK; DOUBLE ANTIBODY SANDWICH ENZYME LINKED IMMUNOSORBENT ASSAY; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; HEART DEATH; HEART FAILURE; HUMAN; KIDNEY FUNCTION; KIDNEY INJURY; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; QUALITY CONTROL; AGED; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; EPIDEMIOLOGY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; UNITED STATES; URINALYSIS; URINE;

ACETYLGLUCOSAMINIDASE; AGED; BIOMARKERS; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; FATTY ACID-BINDING PROTEINS; FEMALE; HEPATITIS A VIRUS CELLULAR RECEPTOR 1; HUMANS; LIPOCALIN-2; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES; URINALYSIS;

EID: 85021702854     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08560816     Document Type: Article

References (24)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004 2. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA: Tubular kidney injurymolecule-1 (KIM-1) in human renal disease. J Pathol 212: 209-217, 2007
2. PeraltaCA, Katz R, Bonventre JV, Sabbisetti V, SiscovickD, Sarnak M, Shlipak MG: Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in theMulti-Ethnic Study of Atherosclerosis (MESA). Am J Kidney Dis 60: 904-911, 2012
3. Bolignano D, Lacquaniti A, Coppolino G, Donato V, Campo S, FazioMR, NicociaG, BuemiM:Neutrophil gelatinase-associated lipocalin(NGAL)andprogressionof chronic kidneydisease. Clin J Am Soc Nephrol 4: 337-344, 2009
4. LiuKD,YangW,GoAS,AndersonAH,FeldmanHI, FischerMJ,He J, Kallem RR, Kusek JW, Master SR, Miller ER 3rd, Rosas SE, Steigerwalt S, Tao K,WeirMR, Hsu CY; CRIC Study Investigators: Urine neutrophil gelatinase-associated lipocalin and risk of cardiovascular disease and death in CKD: Results from the chronic renal insufficiency cohort (CRIC) Study.AmJ KidneyDis 65: 267-274, 2015
5. Gammelager H, Christiansen CF, Johansen MB, Tønnesen E, Jespersen B, Sørensen HT: Three-year risk of cardiovascular disease among intensive care patients with acute kidney injury: A population-based cohort study. Crit Care 18: 492, 2014
6. Peralta C, Scherzer R,GrunfeldC, AbrahamA,TienP,DevarajanP, BennettM, Butch A, Anastos K, Cohen M, Nowicki M, Sharma A, Young M, Sarnak M, Parikh C, Shlipak M: Urinary biomarkers of kidney injuryareassociatedwithall-causemortality intheWomen’s Interagency HIV Study (WIHS). HIV Med 15: 291-300, 2014
7. Bansal N, Carpenter MA,Weiner DE, Levey AS, Pfeffer M, Kusek JW, Cai J,Hunsicker LG, ParkM,BennettM,LiuKD,HsuCY:Urine injury biomarkers and risk of adverse outcomes in recipients of prevalent kidney transplants: The folic acid for vascular outcome reduction in transplantation trial. J Am Soc Nephrol 27: 2109-2021, 2016
8. Ko GJ, Grigoryev DN, Linfert D, Jang HR, Watkins T, Cheadle C, Racusen L, Rabb H: Transcriptional analysis of kidneys during repair from AKI reveals possible roles for NGAL and KIM-1 as biomarkers of AKI-to-CKD transition. Am J Physiol Renal Physiol 298: F1472-F1483, 2010
9. Sinha V, Vence LM, Salahudeen AK. Urinary tubular proteinbased biomarkers in the rodent model of cisplatin nephrotoxicity: A comparative analysis of serum creatinine, renal histology, and urinary KIM-1, NGAL, and NAG in the initiation, maintenance, and recovery phases of acute kidney injury. J Investig Med 2013; 61(3):564-568.
10. KamijoA, Kimura K, Sugaya T, Yamanouchi M, HikawaA, Hirano N, Hirata Y,Goto A, Omata M: Urinary fatty acid-binding protein as a new clinical marker of the progression of chronic renal disease. J Lab Clin Med 143: 23-30, 2004
11. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED,Go AS, HammLL, He J, Hostetter T,HsuCY, JamersonK, JoffeM,Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER 3rd, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators: The chronic renal insufficiency cohort (CRIC) study: Designand methods. JAmSocNephrol 14[Suppl 2]: S148-S153, 2003
12. Fischer MJ, Go AS, Lora CM, Ackerson L, Cohan J, Kusek JW, Mercado A, Ojo A, Ricardo AC, Rosen LK, Tao K, Xie D, Feldman HI, Lash JP; CRIC and H-CRIC Study Groups: CKD in Hispanics: Baseline characteristics from the CRIC (chronic renal insufficiency cohort) and Hispanic-CRIC Studies. Am J Kidney Dis 58: 214-227, 2011
13. Lash JP, Go AS, Appel LJ, He J, Ojo A, Rahman M, Townsend RR, Xie D, Cifelli D, Cohan J, Fink JC, Fischer MJ, Gadegbeku C, Hamm LL, Kusek JW, Landis JR, Narva A, Robinson N, Teal V, Feldman HI; Chronic Renal Insufficiency Cohort (CRIC) Study Group: Chronic renal insufficiency cohort (CRIC) study: Baseline characteristics and associations with kidney function. Clin J Am Soc Nephrol 4: 1302-1311, 2009
14. Hsu C-y, Xie D, Waikar SS, Bonventre JV, Zhang X, Sabbisetti V, Mifflin TE, Coresh J, Diamantidis CJ, He J, Lora CM, Miller ER, Nelson RG, OjoAO, Rahman M, Schelling JR, Wilson FP, Kimmel PL, Feldman HI, Vasan RS, Liu KD; CRICStudy Investigators:CKD Biomarkers Consortium: Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. [published online ahead of print October 28, 2016] Kidney Int: 10.1016/j.kint.2016.09.003
15. Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD; Chronic Kidney Disease Biomarkers Consortium Investigators: Association of urinary KIM-1, L-FABP,NAGandNGALwith incident endstage renal disease andmortality in American Indianswith type 2 diabetes mellitus. Diabetologia 58: 188-198, 2015
16. Foster MC, Coresh J, Bonventre JV, Sabbisetti VS, Waikar SS, Mifflin TE, Nelson RG, Grams M, Feldman HI, Vasan RS, Kimmel PL, Hsu CY, Liu KD; CKD Biomarkers Consortium: Urinary biomarkers and risk of ESRD in the atherosclerosis risk in communities study. Clin J Am Soc Nephrol 10: 1956-1963, 2015
17. Hsu CY, Ballard S, Batlle D, Bonventre JV, Bo¨ ttinger EP, Feldman HI, Klein JB,Coresh J, Eckfeldt JH, Inker LA, Kimmel PL, KusekJW, LiuKD,MauerM, Mifflin TE,MolitchME, NelsestuenGL,Rebholz CM, Rovin BH, Sabbisetti VS, Van Eyk JE, Vasan RS, Waikar SS, Whitehead KM, Nelson RG; CKD Biomarkers Consortium: Crossdisciplinary biomarkers research: Lessons learned by the CKD biomarkers consortium. Clin J AmSoc Nephrol 10: 894-902, 2015
18. TownsendRR,AndersonAH,ChenJ,GadebegkuCA, FeldmanHI, Fink JC,GoAS, JoffeM,Nessel LA,OjoA,RaderDJ,ReillyMP,Teal V, Teff K, Wright JT, Xie D: Metabolic syndrome, components, and cardiovascular disease prevalence in chronic kidney disease: Findings from the chronic renal insufficiency cohort (CRIC) study. Am J Nephrol 33: 477-484, 2011
19. AndersonAH,YangW,HsuCY, JoffeMM, LeonardMB,XieD,Chen J, Greene T, Jaar BG, Kao P, Kusek JW, Landis JR, Lash JP, Townsend RR,Weir MR, Feldman HI; CRIC Study Investigators: Estimating GFR among participants in the chronic renal insufficiency cohort (CRIC) Study. Am J Kidney Dis 60: 250-261, 2012
20. Helmersson-Karlqvist J, Larsson A, Carlsson AC, Venge P, Sundstro¨m J, Ingelsson E, Lind L, Arnlo¨v J: Urinary neutrophil gelatinase-associated lipocalin (NGAL) is associated with mortality in a community-based cohort of older Swedish men. Atherosclerosis 227: 408-413, 2013
21. Sarnak MJ, Katz R, Newman A, Harris T, Peralta CA, Devarajan P, BennettMR, Fried L, Ix JH, Satterfield S, SimonsickEM, Parikh CR, Shlipak MG; Health ABC Study: Association of urinary injury biomarkers with mortality and cardiovascular events. J Am Soc Nephrol 25: 1545-1553, 2014
22. ShlipakMG, Scherzer R,AbrahamA, Tien PC,GrunfeldC, Peralta CA, Devarajan P, Bennett M, Butch AW, Anastos K, Cohen MH, Nowicki M, Sharma A, Young MA, Sarnak MJ, Parikh CR: Urinary markers of kidney injury and kidney function decline in HIVinfected women. J Acquir Immune Defic Syndr 61: 565-573, 2012
23. Park M, Shlipak MG, Vittinghoff E, Katz R, SiscovickD, Sarnak M, Lima JA, Hsu CY, Peralta CA: Associations of kidney injury markerswithsubclinical cardiovasculardisease:Themulti-ethnic study of atherosclerosis. Clin Nephrol 84: 358-363, 2015
24. Sabbisetti VS, Waikar SS, Antoine DJ, Smiles A, Wang C, Ravisankar A, Ito K, Sharma S, Ramadesikan S, Lee M, Briskin R, De Jager PL, Ngo TT, Radlinski M, Dear JW, Park KB, Betensky R, Krolewski AS, Bonventre JV: Blood kidney injury molecule-1 is a biomarker of acute and chronic kidney injury and predicts progression to ESRD in type I diabetes. J Am Soc Nephrol 25: 2177-2186, 2014